Mental strain behind breastfeeding
It serves as a platform to highlight breastfeeding as a foundation for lifelong health, development, and equity.
Breastfeeding remains one of the most effective ways to ensure a child's health and survival. It provides safe, nutrient-rich nourishment packed with antibodies that protect against illness, while also strengthening the emotional bond between mother and infant.
While physical breastfeeding challenges are often acknowledged, the emotional and psychological toll remains underdiscussed. For many Malaysian mothers, the experience is deeply emotional, entangled with guilt, stress, and isolation.
Breastfeeding in Malaysia is often a mother's determination, supported by encouragement from her partner.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Star
9 hours ago
- The Star
Hepatitis C treatment can be safely shortened
A new clinical trial conducted in Malaysia has found that an eight-week regimen of ravidasvir and sofosbuvir is just as safe and effective as the standard 12-week treatment for chronic hepatitis C. This finding could accelerate efforts to scale up access to treatment in resource-limited settings by reducing treatment duration, costs and system burden. The EASE study (Evaluating Accelerated Shortened treatment for hepatitis C in Asia through real-world Evidence) was led by the Health Ministry (MOH) and conducted across 26 sites nationwide between March 2021 and March 2023. The randomised trial involved 322 patients diagnosed with chronic hepatitis C virus infection, including those with more complex medical profiles. The primary objective was to determine whether an eight-week treatment course using the fixed-dose combination of ravidasvir and sofosbuvir would achieve similar sustained virological response (SVR), compared to the standard 12-week regimen. An SVR refers to the continued absence of the hepatitis C virus in a patient's blood 12 weeks or more after they have completed treatment. It is essentially considered a virological cure for the infection. The study found no significant difference in efficacy between the two durations, with high SVR rates maintained in both arms. Safety profiles were also comparable, with no new adverse effects identified. The results were officially reported by the MOH in January (2025) and presented at the 2025 European Association for the Study of the Liver (EASL) Congress in early May in Amsterdam, the Netherlands. Ravidasvir was co-developed through a public-health partnership involving the MOH, Drugs for Neglected Diseases initiative (DNDi), Pharco Pharmaceuticals (Egypt) and Pharmaniaga Berhad (Malaysia), with key clinical trials conducted in Malaysia and Thailand. The treatment was first registered in Malaysia in 2021 and added to the World Health Organization (WHO) Essential Medicines List in 2023. While hepatitis C continues to affect approximately 50 million people globally, with only about 20% receiving treatment, high drug prices remain a barrier in many countries. A 2023 MOH study estimates 0.4% of the population in Malaysia to have hepatitis C. In line with WHO targets, Malaysia aims to eliminate the disease as a public health threat by 2030.
New Straits Times
15 hours ago
- New Straits Times
IHW 2025 generates RM96mil in sales for Malaysian healthcare firms
KUALA LUMPUR: Malaysian healthcare companies recorded RM96.18 million in sales during the International Healthcare Week (IHW) 2025, held from July 16 to 18 at the Malaysia International Trade and Exhibition Centre (Mitec). The event was organised by UK-based event organiser Informa Markets in strategic partnership with the Malaysia External Trade Development Corporation (Matrade) and featured over 800 exhibitors and attracted more than 22,000 trade visitors. In a statement today, Matrade said the Malaysia Healthcare Day Forum, held during IHW 2025, brought together various ministries and agencies to showcase the country's healthcare ecosystem, highlighting strengths in medical tourism, pharmaceuticals, regulatory standards, and digital health. The event was officiated by Minister of Investment, Trade and Industry, Tengku Datuk Seri Zafrul Abdul Aziz, and also present were Matrade chairman Datuk Seri Reezal Merican Naina Merican and Informa Markets in Asia president and chief executive officer Margaret Ma. Matrade said that 10 Malaysian companies participated under the Malaysia Pavilion, coordinated by the agency, showcasing products ranging from regenerative therapies and diagnostics to wellness supplements and medical disposables. "They successfully generated RM96.18 million in sales, underscoring the event's impact as a high-value platform for international trade and strategic business partnerships in the healthcare sector," it said. Reezal Merican said the initiative has progressed steadily since initial engagements last year, including the inaugural IHW held in Bangkok, driven by ongoing cooperation and development. "Hosting IHW 2025 in Kuala Lumpur marks a transformative leap, as it is not only the largest healthcare trade event in Southeast Asia but also reflects Malaysia's rising stature as a regional healthcare hub," he said. Matrade said that Malaysia's medical device exports grew by 31.6 per cent in 2024 to RM37.03 billion, while pharmaceutical exports increased by four per cent to RM3.04 billion, with key export destinations including the United States, Belgium, Singapore, Germany, and Japan. IHW 2025 also featured four co-located exhibitions, namely CPHI Southeast Asia, WHX Kuala Lumpur, WHX Labs, and Medtec Southeast Asia, along with the Healthcare Information and Management Systems Society (HIMSS) Asia Pacific Conference. A total of 125 conference sessions were held during IHW 2025, focusing on topics such as artificial intelligence in healthcare, pharmaceutical developments, and digital transformation.
New Straits Times
15 hours ago
- New Straits Times
Tobacco Control Alliance: Asean plastic pollution treaty must address toxic cigarette filters
KUALA LUMPUR: The United Nations has been urged to ban plastic-based cigarette filters by the Southeast Asia Tobacco Control Alliance (Seatca), as governments worldwide meet to negotiate a treaty on plastic pollution. Seatca said the final round of negotiations in Geneva this week could either help Asean reverse the plastic pollution crisis or continue to pay US$10 billion (RM42 billion) to clean up toxic cigarette filters. The regional health NGO added that Asean member states, except for Indonesia, are parties to the World Health Organisation's (WHO) Framework Convention on Tobacco Control (FCTC). According to Seatca, an estimated 4.5 trillion cigarette butts are discarded globally each year, with 460 billion of those in Asean. These butts are made of cellulose acetate, a plastic that breaks down slowly into harmful microplastics. They also contain more than 7,000 chemicals, including nicotine and heavy metals, that can leach into the environment and harm ecosystems. Seatca called for the treaty to include a polluter-pays principle, making tobacco manufacturers financially responsible for filter pollution and cleanup. The group also said the treaty should reference the WHO's FCTC, reject industry influence, and ensure consistent alignment between environmental and public health policies. It also called for independent and industry-free public awareness campaigns and mandatory collection and disposal systems for tobacco product waste. The group highlighted that while eco-friendly alternatives exist for products like straws and bags, there are no sustainable alternatives for cigarette filters. It said that products marketed by the tobacco industry as "eco-filters" or "green butts" are misleading because they still release tar, nicotine, and heavy metals into the environment and often only break down under industrial composting conditions. Seatca said these "greenwashing tactics" must not fool negotiators, and that the treaty should include a comprehensive ban on all types of cigarette filters, not just plastic ones. The group added that filters, developed in the 1950s to ease public fears about the health effects of smoking, have failed to protect health.
